Unverified50% confidenceFactExact time

In most solid tumors, only 20–40% of patients produce a durable response to PD-1 monotherapy.

1

Sources

50%

Confidence

Long-term

Relevance

9/7/2026

First Seen

Sources

Moderna's Personalized Cancer Vaccine Succeeds in Phase 3 Trial, Stock Surges 110%

Related Entities

PD-1抑制剂concept

Related Claims

Unverified美国国立癌症研究所（NCI）数据显示，超过95%在小鼠模型中有效的抗癌疗法未能在人体临床试验中复现58% similar UnverifiedAccording to the WHO, long-term medication adherence among chronic disease patients is only about 50% in developed countries57% similar

Cite This Claim

Stable URI

https://kongchang.com/claim/873263

API

curl https://kongchang.com/api/v1/knowledge/claims/873263

MCP

get_claim(id=873263)